罗氏
Integrated Strategy Leader (ISL) - CVRM
Integrated Strategy Leader (ISL) - CVRM
发布于 6 个月前高层管理(VP/总经理/CEO)
上海市
高级经验
全职员工
仅现场办公
医疗、制药与临床研究
制药行业
医学事务
商业战略
定价策略
市场准入
战略分析
管线管理
英语流利
药物开发
AI 估算 · 70k–120k
CVRM领域综合策略负责人，与AD岗位类似，负责核心治疗领域全方位战略，顶级制药企业高管薪资。
职位详情
关于这个职位
作为心血管、肾脏和代谢疾病领域的整合战略负责人，您将组建并领导一支跨职能的中国团队，负责洞察生成、制定并实施整合的疾病领域和资产战略
您将作为罗氏中国与全球组织之间的主要联络点，在药物开发管线中为中国发声并提供战略输入，同时负责中国上市前活动和市场塑造活动的实施
最低要求
BS/BA in Business Administration or Life Sciences, MD, PhD, MBA preferred, management consulting experience in the pharmaceutical industry preferred
+ years multidisciplinary experience in the pharmaceutical or biotechnology industry including commercial experience and demonstration of commercial success
Solid scientific background and understanding with an in-depth knowledge of drug development and the pharmaceutical value chain
Experience and understanding of the pharmaceutical market in the therapeutic area will be strongly considered
Strong learning agility, strategic ability and enterprise thinking
Proven track record of leading successful cross-functional teams and influencing without authority – matrix leadership
Leadership presence with ability to challenge and hold ground with global and affiliate senior leaders
Multi-cultural awareness and ability to operate effectively in the global and local China environment
Advanced communication and presentation skills
Fluent written and spoken English
工作职责
Form and lead a high-performing integrated cross-functional China squad for the disease area consisting of key commercial functions (access, pricing, medical, strategic analytics, etc.), as well as China value chain members (CiCOR, PD-China, manufacturing). The squad will have accountability for insight generation and the development of China-integrated disease area and asset strategies as well as implementation. In addition, will define the squad’s ambition, objectives and key performance metrics
Will play an important role in the performance management, coaching and development of squad members
Act as the Primary Point of Contact (PPOC) to the global organization. You will act as a bridge between Roche China and global stakeholders to amplify China's voice and provide strategic input to the global development of pipeline molecules in the therapeutic area. Works with global teams to provide China insights for the therapeutic area and disease area strategies; develops the China strategy at AS.2, AS.3, for asset strategies during the IDCP process to be presented to global governance (ESPC, LSPC)
Build and maintain trusting relationships with global teams (CET’s, LCT’s) and global stakeholders (DALs, LCLs, CSLs, CELs) by regularly engaging them to understand their needs and challenges
Accountable for the implementation of the China pre-launch, market-shaping activities and resourcing recommendations for the therapeutic area, disease areas and asset strategies prior to passing to the Customer Engagement teams
Face of Roche for engaging key therapeutic and disease area stakeholders, e.g., therapeutic area experts, investigators, patient associations
Therapeutic area and disease area specialist and champion. Possesses deep understanding of the therapeutic area, disease areas, patient journey, current and emerging science, treatments and market
AI 洞察
暂无 AI 洞察数据
职位点评
Watch Jobs